Blood

Nodal marginal zone B-cell lymphoma

ORPHA:86867 ↗

Search all Nodal marginal zone B-cell lymphoma trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

506

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

1 Apr 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2NCT06905509

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Sponsor University of California, DavisWhere United States (1 site)Studying Autologous Hematopoietic Stem Cell Transplantation, CarboplatinUpdated 30 Jun 2026

See details

RecruitingNCT01137825

Registry of Older Patients With Cancer

Sponsor UNC Lineberger Comprehensive Cancer CenterWhere United States (7 sites)Updated 29 Jun 2026

See details

RecruitingNCT05700149

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

Sponsor International Extranodal Lymphoma Study Group (IELSG)Where United States, Argentina, Armenia +12 (50 sites)Updated 22 Jun 2026

See details

RecruitingPhase 1NCT06859008

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Sponsor City of Hope Medical CenterWhere United States (1 site)Studying Biopsy, Biospecimen CollectionUpdated 20 Apr 2026

See details

RecruitingPhase 1NCT05544019

Study of SGR-1505 in Mature B-Cell Neoplasms

Sponsor Schrödinger, Inc.Where United States, France, Italy +5 (36 sites)Studying SGR-1505Updated 13 Feb 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 8 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Argentina Armenia Canada Croatia France India Italy Moldova Netherlands Poland Portugal Romania South Korea Spain Switzerland Ukraine United Kingdom United States

Keep watching

Get an email when a new Nodal marginal zone B-cell lymphoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:86867 ↗

About Nodal marginal zone B-cell lymphoma

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 1/2Ublituximab (Briumvi)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).